Amantadine Therapy for Chronic Hepatitis C: A Randomized Double-blind Placebo-controlled Trial

OBJECTIVE: Although treatment of hepatitis C has improved, up to 50% do not respond to standard therapy with interferon regimes or cannot tolerate the treatment due to side effects. The purpose of the present investigation was to evaluate the safety and effectiveness of the antiviral drug amantadine...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Smith, Jill P, Riley, Thomas R, Devenyi, Attila, Bingaman, Sandra I, Kunselman, Allen
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Science Inc 2004
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1492374/
https://ncbi.nlm.nih.gov/pubmed/15209605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1525-1497.2004.30057.x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky